FARALLON CAPITAL EUROPE: Form 8.3 - Willis Towers Watson PLC

TIDM0Y4Q 
 
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

 
Name of person dealing (Note 1)         Farallon Capital Europe LLP (on behalf 
                                        of funds managed jointly with Farallon 
                                        Capital Management, L.L.C. and 
                                        Farallon Partners, L.L.C.) 
Company dealt in                        Willis Towers Watson PLC 
Class of relevant security to which     US$0.000304635 ordinary shares 
the dealings being disclosed relate 
(Note 2) 
Date of dealing                         04 March 2021 
 

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                              Long             Short 
                                              Number     (%)   Number  (%) 
(1) Relevant securities                       2,786,700  2.16 
(2) Derivatives (other than options) 
(3) Options and agreements to purchase/sell 
Total                                         2,786,700  2.16 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                  Long           Short 
                                             Number    (%)  Number    (%) 
(1) Relevant securities 
(2) Derivatives (other than options) 
(3) Options and agreements to purchase/sell 
Total 
 

3. DEALINGS (Note 4)

(a) Purchases and sales

 
 
 Purchase/sale   Number of relevant securities   Price per unit (Note 5) 
Purchase        45,000                          USD 221.7697 
 

(b) Derivatives transactions (other than options transactions)

 
Product name,  Nature of transaction  Number of relevant        Price per unit 
 e.g. CFD       (Note 6)              securities (Note 7)        (Note 5) 
 
 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

 
Product  Writing,     Number of   Exercise  Type,      Expiry    Option money 
name,    selling,     securities  price     e.g.       date      paid/received 
e.g.     purchasing,  to which              American,            per unit 
call     varying      the option            European             (Note 5) 
option   etc.         relates               etc. 
                      (Note 7) 
 
 

(ii) Exercising

 
Product name,      Number of securities  Exercise price per unit (Note 5) 
 e.g. call option 
 
 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 
Nature of transaction  Details  Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
 
 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 
Full details of any agreement, arrangement or understanding between the person 
disclosing and any other person relating to the voting rights of any relevant 
securities under any option referred to on this form or relating to the voting 
rights or future acquisition or disposal of any relevant securities to which 
any derivative referred to on this form is referenced. If none, this should be 
stated. 
 
 

Is a Supplemental Form 8 attached? (Note 9) Yes

 
Date of disclosure                                             05 March 2021 
Contact name                                                   Caitlin Shreve 
Telephone number                                               [phone] 
If a connected EFM, name of offeree/offeror with which 
 connected 
If a connected EFM, state nature of connection (Note 10) 
 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

 
Product       Written, or   Number of    Exercise     Type, e.g.   Expiry date 
name, e.g.    purchased     relevant     price (Note  American, 
call option                 securities   2)           European 
                            to which                  etc. 
                            the option 
                            or 
                            derivative 
                            relates 
 
 
 

Notes

   1. Where there are open option positions or open derivative positions 
      (except for CFDs), full details should be given. Full details of any 
      existing agreements to purchase or to sell must also be given on this 
      form. 
 
   2. For all prices and other monetary amounts, the currency must be stated. 
 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005078/en/

 
    CONTACT: 

Farallon Capital Europe LLP

 
    SOURCE: Farallon Capital Europe LLP 
Copyright Business Wire 2021 
 

(END) Dow Jones Newswires

March 05, 2021 09:00 ET (14:00 GMT)